CD4+ and CD8+ T cell subsets readily engraft in immune deficient mice [73–75,82–89], with an increased ratio of human CD4+:CD8+ T cells indicative of GVHD severity [90], reflecting observations in allogeneic HSCT recipients [91,92]. This evidence concerns the gene CD8A and graft versus host disease.